WO1988009201A1 - Process and device for separating and cleaning molecules - Google Patents
Process and device for separating and cleaning molecules Download PDFInfo
- Publication number
- WO1988009201A1 WO1988009201A1 PCT/EP1988/000442 EP8800442W WO8809201A1 WO 1988009201 A1 WO1988009201 A1 WO 1988009201A1 EP 8800442 W EP8800442 W EP 8800442W WO 8809201 A1 WO8809201 A1 WO 8809201A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- matrix
- hollow body
- molecules
- solution
- porous
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000004140 cleaning Methods 0.000 title claims abstract description 9
- 230000008569 process Effects 0.000 title abstract description 6
- 239000011159 matrix material Substances 0.000 claims abstract description 42
- 238000001179 sorption measurement Methods 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims description 32
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 150000007523 nucleic acids Chemical class 0.000 claims description 20
- 238000004587 chromatography analysis Methods 0.000 claims description 17
- 238000000746 purification Methods 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- -1 polyethylene Polymers 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 229920000936 Agarose Polymers 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 229920001222 biopolymer Polymers 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 239000012876 carrier material Substances 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920000620 organic polymer Polymers 0.000 claims description 4
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- 108091005461 Nucleic proteins Proteins 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000004809 Teflon Substances 0.000 claims description 2
- 229920006362 Teflon® Polymers 0.000 claims description 2
- 238000001042 affinity chromatography Methods 0.000 claims description 2
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 claims description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 1
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 description 25
- 108020004414 DNA Proteins 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000000243 solution Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 10
- 238000010828 elution Methods 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000007993 MOPS buffer Substances 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079920 digestives acid preparations Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/04—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium
- B01J20/048—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium containing phosphorus, e.g. phosphates, apatites, hydroxyapatites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/283—Porous sorbents based on silica
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/284—Porous sorbents based on alumina
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/285—Porous sorbents based on polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/287—Non-polar phases; Reversed phases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6004—Construction of the column end pieces
- G01N30/603—Construction of the column end pieces retaining the stationary phase, e.g. Frits
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6052—Construction of the column body
- G01N30/6065—Construction of the column body with varying cross section
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6091—Cartridges
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/02—Burettes; Pipettes
- B01L3/0275—Interchangeable or disposable dispensing tips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8804—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 automated systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N2035/1027—General features of the devices
- G01N2035/1048—General features of the devices using the transfer device for another function
- G01N2035/1055—General features of the devices using the transfer device for another function for immobilising reagents, e.g. dried reagents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
Definitions
- the invention relates to a device and a method for separating and purifying molecules from a solution by adsorbing the molecules onto a matrix arranged in the device.
- Chromatography materials of various types have long been used in a tried and tested way for sample preparation in chemically, biochemically and molecular biologically oriented laboratories. Frequently, the samples are obtained on a microscale, in particular in the bio-chemical and molecular biological, but also in the analytical-chemical laboratory.
- the chromatographic materials are also used to extract certain components from the samples.
- the procedure to be referred to as solid phase extraction can also be used to clean and separate substance mixtures in solution.
- Removing and placing a storage container poses a risk of contamination for the employee, the environment and the sample itself.
- the danger exists particularly in the medical-technical field, for example when working with infectious material, or also in biochemical-molecular biological Laboratories, especially when handling radioactive substances.
- the object of the invention is therefore to provide a device which enables
- the object is achieved according to the invention by a device which is characterized in that the Matrix 2 in a truncated cone-shaped hollow body 1 open at both ends 4a, 4b, to which a cylindrical hollow body adjoins optionally at the further opening 4a, permeable to the solution between two
- Devices 3a, 3b is arranged, wherein the matrix 2 and the devices 3a, 3b together 5 to 50% of the
- Fill the volume of the hollow body and the further opening 4a of the frustoconical hollow body 1 can be connected to a pipette.
- Figures 1 and 2 show schematically the structure of a preferred embodiment of the device according to the invention.
- the matrix 2 is delimited by two devices 3a, 3b which simultaneously ensure that the matrix 2 is fixed in the selected position.
- the devices 3a, 3b are preferably clamped to the wall of the hollow body 1. However, in addition to fastening by tension, fastening by gluing the devices can also be achieved. Both methods lead to an adequate seal between the devices 3a, 3b and the wall of the hollow body 1.
- the further opening 4a of the two openings 4a and 4b is designed such that they fit on a commercially available pipette.
- a preferred embodiment of the device according to the invention consists in that the hollow body 1 is designed in the form of a pipette tip commercially available from specialist dealers (Brand, Gilson, Eppendorf).
- the matrix 2 of the device according to the invention preferably consists of a porous chromatography material, in particular based on silica gel, aluminum oxide, titanium dioxide, hydroxylapatite, dextran, agarose, acrylamide, polystyrene, polyvinyl alcohol . or other organic polymers, derivatives or from copolymers of the abovementioned carrier materials.
- the material forming the matrix 2 can also be a surface-modified, porous chromatography material based on silica gel, aluminum oxide, titanium dioxide,
- Hydroxyapatite dextran, agarose, acrylic acid, polystyrene, polyvinyl alcohol or other organic polymers, derivatives or from copolymers of the abovementioned carrier materials.
- ion exchange materials can be used as matrix 2 of the device according to the invention for the separation and purification of polar molecules.
- Further preferred embodiments of the device according to the invention can contain a reversed-phase and / or an affinity chromatography material as matrix 2.
- the pore size of the porous chromatography materials is preferably 20 to 1000 nm, and the grain size of the materials in particular 10 to 2000 ⁇ m, preferably 75 ⁇ m to 125 ⁇ m.
- the devices 3a, 3b fixing the matrix 2 are preferably designed as porous frits with pore sizes of 10 ⁇ m to 1 mm, preferably 70 ⁇ m to 2000 ⁇ m.
- the porous frits can consist of plastics, in particular Teflon (PTFE), polyethylene, polypropylene, polystyrene, polyurethane etc.
- PTFE Teflon
- inorganic materials such as glass and / or sintered metal are also suitable materials for the production of the porous frits.
- FIGS. 3a and 3b show a further embodiment of the device according to the invention, the simple manufacture of which is particularly advantageous.
- a removable cartridge 5 is inserted into the hollow body 1 and contains the matrix 2 between the devices 3a and 3b fixing the matrix.
- the device 3b is arranged above a net-like carrier 6, which preferably consists of the same material as the removable cartridge 5.
- the net-like carrier 6 and the cartridge 5 are produced in one operation, for example in the injection molding process, if cartridges are made of plastic, in particular polypropylene, the device 3a is arranged above the matrix 2 which in turn is arranged a porous, mesh-like cover 7.
- FIG. 3b shows the overall arrangement, consisting of hollow body 1 and removable cartridge 5.
- This overall arrangement, consisting of cartridge 5, devices 3a, b and cover 7 fixing the matrix 2 can be combined in a particularly advantageous manner with commercially available pipette tips become. In the simplest case, this is done by pushing the removable cartridge 5 into the corresponding hollow body 1, in particular a pipette tip.
- the cartridge 5 is dimensioned so that it exerts a slight pressure on the inner walls of the pipette tip in order not to be pushed up when absorbing liquid or a sample or to provide the necessary seal to the inner wall of the hollow body 1, preferably a pipette tip, and the
- the wall thickness of the removable cartridge 5 of the mesh-like carrier 6 and of the porous mesh-like cover 7 is matched to the pipette tip used.
- the advantage of the device according to the invention lies in the practical handling and the type of packing of the matrix 2, which allows the solution containing the molecules to flow in the back and forth direction.
- the frustoconical hollow body 1 is designed, for example, as a pipette tip, the pipette tip is immersed in the sample, the sample in the pipette tip is sucked up through the matrix 2 and then pressed out. This results in a higher efficiency of the adsorption, since the sample passes through the chromatographic material twice. Since it is possible to work with a closed system, contamination of the sample or danger to the environment is avoided.
- the device according to the invention simplifies the overall method of operation which is to be used in the separation and purification of molecules.
- biopolymers in particular nucleic acids and proteins, can also be fractionated quickly, easily and reliably.
- the method according to the invention is carried out in a special embodiment with a hollow body 1 designed as a pipette tip.
- the molecules containing, separating and cleaning the molecules can then be conveyed through the matrix 2 by means of a pipette. If the pipette tip is to be used as a column replacement in conventional processes, then - 1 -
- the pipette tip can also be connected to a disposable syringe using a silicone tube.
- the method according to the invention is suitable, in particular, for separating and purifying biopolymers such as nucleic acids and proteins by using ion exchange chromatography materials as proposed in German patent application P 36 39 949.3 as the matrix 2. It is silica gel-based chromatography material modified on the surface with anion exchange groups. If, for example, the matrix 2 is in a pipette tip, the nucleic acid is sucked through the matrix 2 with the pipette. The long-chain nucleic acids are adsorbed using buffers of low ionic strength. If you then want to utilize the short-chain nucleic acids, you push the solution back through the matrix 2 and catch it. Then further procedural steps can follow.
- the long-chain nucleic acids can be eluted again by elution with buffers of high salt concentration (high ionic strength) and processed accordingly.
- FIG. 4 shows an elution profile which can be obtained when anion exchange materials are used when using the device according to the invention. It has been shown that when using the material proposed for the separation of nucleic acids in German patent application P 36 39 949.3, an elution profile is obtained by means of which nucleic acids with increasing chain length can be eluted with increasing ionic strength. Thus, double-stranded DNA with base pairs> 500 is only obtained with an ionic strength of 1.3 M sodium chloride, while single-stranded DNA of the phage M 13 is eluted at 1.1 M sodium chloride. The elution peaks are so sharp that even "baseline" separations are possible. At an average ionic strength between 0.5 and 1 M sodium chloride, nucleic acids such as tRNA, 5 RNA and mRNA elute. At low ionic strengths of 0.1 to 0.5, polysaccharides,
- Proteins such as BSA (bovine serum albumin) and smaller ones
- a variant of the method consists in using an affinity adsorbent as matrix 2, as is proposed, for example, in German patent application P 36 27 063.
- the procedure is carried out analogously to the procedure described above.
- the method according to the invention ensures the following advantages, in particular in molecular biological operations:
- the purity in routine preparations obtainable when using the device according to the invention is at least comparable to samples obtained by Caesiu chloride density gradient centrifugation.
- the isolated nucleic acids are free of proteins, polysaccharides and other cell metabolites and show no inhibition of enzymes in enzymatic reactions.
- the device according to the invention can be used for the isolation and purification of nucleic acids from oligonucleotides to plasmids, the time expenditure being restricted to fractions in comparison to other processes.
- the device according to the invention is suitable for use in a separation and purification process for molecules, preferably biopolymers such as proteins and / or nucleic acids, in particular of other cell components.
- the use of the device according to the invention in various processes is explained in more detail in the following examples.
- the device according to the invention is used in a preferred embodiment, the pipette tip.
- a 70 ⁇ polyethylene frit with a 4 mm diameter and a thickness of 1.6 mm is introduced into a 1 ml pipette tip, suitable for Gilson Pipetan, and clamped by pressing. Then about 70 mg of the chromatographic material, proposed in German patent application P 36 39 949, are filled in dry. The chromatographic material is closed with a 5.7 mm diameter frit as described above and the frit is fixed in place by pressing. The procedure is analogous for 200 ⁇ l pipette tips or 5000 ⁇ l pipette tips.
- the pipette tip is equilibrated once with 100 ⁇ l of a suitable adsorption buffer. With a sample volume of 100 to 200 ⁇ l to be processed, it is sufficient to push the sample through the chromatography material about five times. However, if a larger amount of liquid is to be processed, such as is obtained after gel elution, the sample can be drawn through the matrix using a silicone tube that connects the pipette tip and a disposable syringe. It is then sufficient for the sample to pass the chromatography material only twice. The flow rate of the solution should not be higher than 1 ml per minute.
- Buffer A can be used as equilibration and adsorption buffer. Buffer A:
- buffers B, C and D are typically used as washing buffers.
- Buffer B Buffer C:
- An Eppendorf tube is filled with 1 ml of washing buffer and 150 ⁇ l are rinsed three times through the chromatography material in order to remove impurities. This step is repeated.
- the adsorbed nucleic acids are eluted either with an Eppendorf or Gilson pipette or with a disposable syringe, care being taken that the pipette tip is connected to the disposable syringe by means of a silicone tube. It simply becomes the elution buffer E or F
- Buffer E Buffer F:
- a pipette tip, produced according to Example 1, is hydrated with 50 mM sodium phosphate buffer and equilibrated by passing 750 ⁇ l buffer several times through the
- Pipette sucks.
- a plasmid DNA sample is typically obtained in a so-called mini-preparation by the following steps:
- the bacterial cells are incubated overnight and harvested the next day by centrifugation.
- the pellet is disrupted in 85 ⁇ l of an ice-cold solution of 50 mM Tris-HCl, pH 7.4, with 2 mg / ml lysozyme (freshly prepared) and incubated on ice for 10 minutes.
- 20 ⁇ l of a 0.5 M EDTA solution are added and incubated for a further 10 minutes.
- After adding 4 ⁇ l of 2% Triton X '100 the mixture is incubated on ice for a further hour.
- the sample is centrifuged in a laboratory centrifuge for 30 minutes at maximum speed, and 100 ⁇ l of the cell lysate freed from cell debris are transferred to another Eppendorf tube, after which 1 volume of 2 M sodium chloride, 100 mM MOPS, pH 7 and 5 ⁇ l Isoa yl alcohol can be added.
- a pipette tip according to the invention from Gilson, Brand, Eppendorf, manufactured according to Example 1, is equilibrated with 100 ⁇ l buffer C. Then 100 ⁇ l of an E. coli plasmid DNA sample is adsorbed on the chromatography material by pipetting the sample up and down five times.
- RNA extract is precipitated with ethanol and the pellet obtained is resuspended in TE buffer (10 mM Tris / 1 mM EDTA, pH 7.5).
- TE buffer 10 mM Tris / 1 mM EDTA, pH 7.5.
- the adsorption conditions are adjusted by adding 0.1 part by volume (based on the re-suspended solution) of 5 M sodium chloride and 0.2 part by volume of 250 mM MOPS, pH 7.0.
- the pipette tip is equilibrated with 1 ⁇ l buffer A.
- the sample is then adsorbed onto the chromatography material by pipetting up and down five times. One rinses with buffer A in order to eliminate impurities. Elution is carried out with 300 ⁇ l of buffer C.
- the RNA is precipitated by adding 2.5 parts by volume of ethanol. After standing at -20 ° C. for 30 minutes, centrifugation in an Eppendorf centrifuge takes a total of 30 minutes at the highest speed. The pellet
- the labeling reaction of the DNA is terminated by adding 2 ⁇ l 0.5 M EDTA per 20 ⁇ l sample volume, and the adsorption conditions are adjusted by adding 1 volume part of the buffer C.
- the total final salt concentration should be approximately 500 mM.
- the pipette tip according to the invention is equilibrated with 100 ⁇ l buffer B.
- the sample is adsorbed onto the chromatography material by suction up five times and squeezed out and washed with a total of 10 ml of buffer B in order to separate the unreacted nucleotides.
- the flow rate of the washing buffer should preferably be approximately 5 ml per minute.
- the labeled DNA is then eluted with a total of 300 ⁇ l of the buffer F.
- the sample can be used directly if it is diluted at least 1:20 with the buffer intended for hybridization. Otherwise the sample is precipitated and dissolved in TE buffer.
- the removal of a DNA linker from a DNA with more than approx. 400 base pairs in a cloning experiment is carried out as follows:
- the sample to be cleaned is diluted with 1 part by volume of the buffer C so that the final concentration of salt is approximately 500 mM.
- the pipette tip according to the invention is equilibrated with 100 ⁇ l of buffer A.
- the sample is adsorbed as in the previous examples.
- the pipette tip according to the invention is rinsed with buffer B in order to remove the contaminants.
- the DNA is desorbed and eluted with a total of 300 ⁇ l of buffer F.
- DNA is isolated by isopropanol precipitation (addition of 1 part by volume) and left on ice for 15 minutes, after which the sample is centrifuged in an Eppendorf centrifuge for the Duration of 30 minutes. Then wash carefully with 70% ethanol.
- the underlying reaction volume is 50 ⁇ l and contains no more than 100 mM sodium chloride. 5 ⁇ l of 0.5 M EDTA, pH 8.0, are added to the reaction volume in order to terminate the modification reaction. A volume part of the buffer C is added in order to set the adsorption conditions with a salt concentration of about 500 mM.
- the pipette tip according to the invention is equilibrated, the sample is adsorbed and then eluted as described in Example 8. The further treatment of the sample is also carried out as described in Example 8.
- the device according to the invention can also be used to efficiently separate agarose and acrylamide impurities. This is particularly necessary when gel elution of the sample has taken place.
- the DNA is concentrated at the same time, even if the starting volume is a few ml.
- the DNA has a size of> 400 base pairs and can be present in an amount from 5 ng to 15 ⁇ g.
- the sample preparation and the equilibration of the pipette tip according to the invention is carried out as described in Example 8.
- the sample is then transferred to a disposable syringe and pressed twice through the pipette tip according to the invention.
- the flow rate should be around 250 ⁇ l / in.
- the pipette tip according to the invention is then washed with 5 ml of buffer B at a flow rate of 5 ml / min.
- the further treatment of the DNA sample is carried out as described in Example 8.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873717211 DE3717211A1 (de) | 1987-05-22 | 1987-05-22 | Vorrichtung und verfahren zur trennung und reinigung von molekuelen |
DEP3717211.5 | 1987-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1988009201A1 true WO1988009201A1 (en) | 1988-12-01 |
Family
ID=6328135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1988/000442 WO1988009201A1 (en) | 1987-05-22 | 1988-05-19 | Process and device for separating and cleaning molecules |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE3717211A1 (enrdf_load_stackoverflow) |
WO (1) | WO1988009201A1 (enrdf_load_stackoverflow) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003374A3 (de) * | 1991-07-26 | 1993-05-27 | Univ Schiller Jena | Verfahren und anordnung zur analyse von agglutinationsreaktionen |
WO1993019368A1 (de) * | 1992-03-18 | 1993-09-30 | Abion Ohg Dr. Erhardt U. Maier | Einwegreaktionsgefäss für die festphasenimmunanalytik und verfahren zur messung von über immunreaktionen bestimmbaren komponenten |
EP0587951A1 (en) * | 1992-09-18 | 1994-03-23 | AMERSHAM INTERNATIONAL plc | Cell nuclei capture method and device used therefor |
EP0691148A3 (enrdf_load_stackoverflow) * | 1991-04-03 | 1996-01-24 | Perkin Elmer Corp | |
EP0688426A4 (enrdf_load_stackoverflow) * | 1993-03-08 | 1996-01-31 | ||
US5556598A (en) * | 1992-09-18 | 1996-09-17 | Amersham International Plc. | Device and method for affinity separation |
DE19806780C1 (de) * | 1998-02-18 | 1999-07-01 | November Ag Molekulare Medizin | Vorrichtung zur Isolierung und Aufreinigung von Nukleinsäuren |
EP1015098A4 (en) * | 1997-02-26 | 2000-08-09 | Millipore Corp | CAST MEMBRANE STRUCTURES FOR THE PREPARATION OF SAMPLES |
EP1362126A4 (en) * | 2001-01-18 | 2004-07-21 | Kemmons A Tubbs | INTEGRATED HIGH THROUGHPUT SYSTEM FOR ANALYZING BIOMOLECULES |
JP2005521041A (ja) * | 2002-03-19 | 2005-07-14 | ウオーターズ・インベストメンツ・リミテツド | 固相抽出用装置および分析前に試料を精製する方法 |
US6998047B1 (en) | 1997-02-26 | 2006-02-14 | Millipore Corporation | Cast membrane structures for sample preparation |
US7163660B2 (en) | 2000-05-31 | 2007-01-16 | Infineon Technologies Ag | Arrangement for taking up liquid analytes |
GB2439050A (en) * | 2006-06-13 | 2007-12-19 | Zhanren Zhang | Disposable chromatography device |
US7482169B2 (en) | 2002-07-15 | 2009-01-27 | Phynexus, Inc. | Low dead volume extraction column device |
US7488603B2 (en) | 2003-07-14 | 2009-02-10 | Phynexus, Inc. | Method and device for extracting an analyte |
EP2024725A4 (en) * | 2007-05-08 | 2009-06-17 | Varian Inc | SAMPLE PREPARATION AND METHOD USING POLYMIDE TUBES |
US7601491B2 (en) | 2003-02-06 | 2009-10-13 | Becton, Dickinson And Company | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
US7722820B2 (en) | 2004-11-19 | 2010-05-25 | Phynexus, Inc. | Method and device for sample preparation |
WO2010093998A2 (en) | 2009-02-14 | 2010-08-19 | Diffinity Genomics, Inc. | System and methods for purifying biological materials |
US8413489B2 (en) | 2007-06-19 | 2013-04-09 | Universal Bio Research Co., Ltd. | Column tip processing device and column tip processing method |
US8691969B2 (en) | 1994-12-12 | 2014-04-08 | Life Technologies As | Isolation of nucleic acid |
US9114383B2 (en) | 2003-07-14 | 2015-08-25 | Phynexus, Inc. | Method and device for extracting an analyte |
EP2274099A4 (en) * | 2008-03-28 | 2016-05-11 | Biotix Inc | SAMPLE PREPARATION DEVICES AND PROCESSES FOR PROCESSING ANALYTES |
US20170292123A1 (en) * | 2014-08-13 | 2017-10-12 | Axagarius Gmbh & Co. Kg | Device for purifying nucleic acids |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5437979A (en) * | 1989-07-24 | 1995-08-01 | Beckman Instruments, Inc. | Solid phase system for sequential reactions |
US5395521A (en) * | 1991-05-31 | 1995-03-07 | Board Of Regents, The University Of Texas System | Automated column equilibration, column loading, column washing and column elution |
DE4143639C2 (de) * | 1991-12-02 | 2002-10-24 | Qiagen Gmbh | Verfahren zur Isolierung und Reinigung von Nukleinsäuren |
US5438128A (en) * | 1992-02-07 | 1995-08-01 | Millipore Corporation | Method for rapid purifiction of nucleic acids using layered ion-exchange membranes |
DE4321904B4 (de) * | 1993-07-01 | 2013-05-16 | Qiagen Gmbh | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen |
WO1999024138A1 (en) * | 1997-11-12 | 1999-05-20 | Life Technologies, Inc. | Device and methods for purifying biological molecules using low volumes of chromatographic and adsorptive media |
CZ9900769A3 (cs) * | 1999-03-04 | 2000-10-11 | Petr Ing. Drsc. Hušek | Použití špičky s filtrem k vytvoření sloupce sorbentu s definovaným objemem v prostoru pod filtrem |
CZ9900770A3 (cs) * | 1999-03-04 | 2000-10-11 | Petr Ing. Drsc. Hušek | Způsob přípravy vzorků pro analýzu aminokyselin a souprava pro tuto přípravu |
AT414209B (de) * | 2000-03-17 | 2006-10-15 | Greiner Bio One Gmbh | Sammelgefäss für flüssigkeiten |
JP2001281117A (ja) * | 2000-03-24 | 2001-10-10 | Millipore Corp | 試料調製装置及び試料調製装置形成方法 |
US7374724B2 (en) | 2001-05-29 | 2008-05-20 | Tecan Trading Ag | Device for processing samples, use of the device, and method for producing the device |
WO2006012486A2 (en) * | 2004-07-23 | 2006-02-02 | Biosystem Development, Llc | Immunoassay assembly and methods of use |
DE102005005437A1 (de) | 2005-02-05 | 2006-08-10 | Eppendorf Ag | Filterpipettenspitze |
US8012349B2 (en) | 2006-11-20 | 2011-09-06 | Orbital Biosciences, Llc | Small volume unitary molded filters and supports for adsorbent beds |
ES2928505T3 (es) | 2015-04-23 | 2022-11-18 | Ist Innuscreen Gmbh | Dispositivo y procedimiento para la extracción de ácidos nucleicos |
DE102015211394B4 (de) | 2015-06-19 | 2022-07-28 | Ist Innuscreen Gmbh | Vorrichtung und Verfahren zur Extraktion von Nukleinsäuren |
DE102015211393A1 (de) | 2015-06-19 | 2016-12-22 | Aj Innuscreen Gmbh | Vorrichtung und Verfahren zur automatisierten Extraktion von Nukleinsäuren |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2452274A1 (de) * | 1974-11-04 | 1976-05-06 | Wuest Heinz Dr Med | Vorrichtung zum abtrennen chemischer stoffe aus loesungen (batch-geraet) |
US3985032A (en) * | 1975-11-13 | 1976-10-12 | Centaur Chemical Co. | Micropipette filter tips |
FR2498331A1 (fr) * | 1981-01-20 | 1982-07-23 | Kadouche Jean | Recipient reactif pour analyse notamment immunologique |
EP0198413A2 (en) * | 1985-04-12 | 1986-10-22 | E.I. Du Pont De Nemours And Company | Rapid assay processor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3211309A1 (de) * | 1982-03-26 | 1983-09-29 | Metin Dipl.-Ing. 6100 Darmstadt Colpan | Chromatographisches verfahren zur isolierung von makromolekuelen |
-
1987
- 1987-05-22 DE DE19873717211 patent/DE3717211A1/de active Granted
-
1988
- 1988-05-19 WO PCT/EP1988/000442 patent/WO1988009201A1/de unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2452274A1 (de) * | 1974-11-04 | 1976-05-06 | Wuest Heinz Dr Med | Vorrichtung zum abtrennen chemischer stoffe aus loesungen (batch-geraet) |
US3985032A (en) * | 1975-11-13 | 1976-10-12 | Centaur Chemical Co. | Micropipette filter tips |
FR2498331A1 (fr) * | 1981-01-20 | 1982-07-23 | Kadouche Jean | Recipient reactif pour analyse notamment immunologique |
EP0198413A2 (en) * | 1985-04-12 | 1986-10-22 | E.I. Du Pont De Nemours And Company | Rapid assay processor |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0691148A3 (enrdf_load_stackoverflow) * | 1991-04-03 | 1996-01-24 | Perkin Elmer Corp | |
WO1993003374A3 (de) * | 1991-07-26 | 1993-05-27 | Univ Schiller Jena | Verfahren und anordnung zur analyse von agglutinationsreaktionen |
WO1993019368A1 (de) * | 1992-03-18 | 1993-09-30 | Abion Ohg Dr. Erhardt U. Maier | Einwegreaktionsgefäss für die festphasenimmunanalytik und verfahren zur messung von über immunreaktionen bestimmbaren komponenten |
US5833927A (en) * | 1992-09-18 | 1998-11-10 | Amersham International Plc | Device and method for affinity separation |
EP0587951A1 (en) * | 1992-09-18 | 1994-03-23 | AMERSHAM INTERNATIONAL plc | Cell nuclei capture method and device used therefor |
US5447864A (en) * | 1992-09-18 | 1995-09-05 | Amersham International Limited | Capture method for cell nucei using a DNA mesh |
US5556598A (en) * | 1992-09-18 | 1996-09-17 | Amersham International Plc. | Device and method for affinity separation |
US5876918A (en) * | 1993-03-08 | 1999-03-02 | Hydros, Inc. | Aligned fiber diagnostic chromatography with positive and negative controls |
EP0688426A4 (enrdf_load_stackoverflow) * | 1993-03-08 | 1996-01-31 | ||
US8691969B2 (en) | 1994-12-12 | 2014-04-08 | Life Technologies As | Isolation of nucleic acid |
EP1015098A4 (en) * | 1997-02-26 | 2000-08-09 | Millipore Corp | CAST MEMBRANE STRUCTURES FOR THE PREPARATION OF SAMPLES |
US6200474B1 (en) | 1997-02-26 | 2001-03-13 | Millipore Corporation | Cast membrane structures for sample prepartion |
US6635201B1 (en) | 1997-02-26 | 2003-10-21 | Millipore Corporation | Cast membrane structures for sample preparation |
US6830717B2 (en) | 1997-02-26 | 2004-12-14 | Millipore Corporation | Cast membrane structures for sample preparation |
US6875354B1 (en) | 1997-02-26 | 2005-04-05 | Millipore Corporation | Cast membrane structures for sample preparation |
US6998047B1 (en) | 1997-02-26 | 2006-02-14 | Millipore Corporation | Cast membrane structures for sample preparation |
DE19806780C1 (de) * | 1998-02-18 | 1999-07-01 | November Ag Molekulare Medizin | Vorrichtung zur Isolierung und Aufreinigung von Nukleinsäuren |
US7163660B2 (en) | 2000-05-31 | 2007-01-16 | Infineon Technologies Ag | Arrangement for taking up liquid analytes |
EP1362126A4 (en) * | 2001-01-18 | 2004-07-21 | Kemmons A Tubbs | INTEGRATED HIGH THROUGHPUT SYSTEM FOR ANALYZING BIOMOLECULES |
JP2005521041A (ja) * | 2002-03-19 | 2005-07-14 | ウオーターズ・インベストメンツ・リミテツド | 固相抽出用装置および分析前に試料を精製する方法 |
EP1485179A4 (en) * | 2002-03-19 | 2007-08-08 | Waters Investments Ltd | SOLID STATE EXTRACTION DEVICE AND METHOD OF PURIFYING SAMPLES BEFORE THE ANALYSIS |
US7482169B2 (en) | 2002-07-15 | 2009-01-27 | Phynexus, Inc. | Low dead volume extraction column device |
US7601491B2 (en) | 2003-02-06 | 2009-10-13 | Becton, Dickinson And Company | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
US7488603B2 (en) | 2003-07-14 | 2009-02-10 | Phynexus, Inc. | Method and device for extracting an analyte |
US9114383B2 (en) | 2003-07-14 | 2015-08-25 | Phynexus, Inc. | Method and device for extracting an analyte |
US7837871B2 (en) | 2003-07-14 | 2010-11-23 | Phynexus, Inc. | Method and device for extracting an analyte |
US7943393B2 (en) | 2003-07-14 | 2011-05-17 | Phynexus, Inc. | Method and device for extracting an analyte |
US7722820B2 (en) | 2004-11-19 | 2010-05-25 | Phynexus, Inc. | Method and device for sample preparation |
GB2439050A (en) * | 2006-06-13 | 2007-12-19 | Zhanren Zhang | Disposable chromatography device |
US8883089B2 (en) | 2007-05-08 | 2014-11-11 | Agilent Technologies, Inc. | Sample preparation device and method utilizing polyamide tube |
EP2024725A4 (en) * | 2007-05-08 | 2009-06-17 | Varian Inc | SAMPLE PREPARATION AND METHOD USING POLYMIDE TUBES |
US8413489B2 (en) | 2007-06-19 | 2013-04-09 | Universal Bio Research Co., Ltd. | Column tip processing device and column tip processing method |
EP2274099A4 (en) * | 2008-03-28 | 2016-05-11 | Biotix Inc | SAMPLE PREPARATION DEVICES AND PROCESSES FOR PROCESSING ANALYTES |
WO2010093998A2 (en) | 2009-02-14 | 2010-08-19 | Diffinity Genomics, Inc. | System and methods for purifying biological materials |
US20170292123A1 (en) * | 2014-08-13 | 2017-10-12 | Axagarius Gmbh & Co. Kg | Device for purifying nucleic acids |
Also Published As
Publication number | Publication date |
---|---|
DE3717211A1 (de) | 1988-12-01 |
DE3717211C2 (enrdf_load_stackoverflow) | 1991-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1988009201A1 (en) | Process and device for separating and cleaning molecules | |
EP0616639B1 (de) | Vorrichtung und verfahren zur isolierung und reinigung von nukleinsäuren | |
EP1121460B1 (de) | Verfahren und mittel zur isolierung und reinigung von nukleinsäuren an oberflächen | |
DE4321904B4 (de) | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen | |
EP3286312B1 (de) | Vorrichtung und verfahren zur extraktion von nukleinsäuren | |
EP0555270A1 (de) | Verfahren zur isolierung von nukleinsäuren aus zellsuspensionen. | |
DE19512369A1 (de) | Vorrichtung zur Isolierung von Nukleinsäuren | |
EP1075546A1 (de) | Verfahren und vorrichtung zur isolierung von nukleinsäuren | |
EP1123980B1 (de) | System zur einfachen Nukleinsäureanalytik | |
DE69817818T2 (de) | Einstufige vorrichtung und verfahren zur konzentration und säuberung biologischer moleküle | |
DE202015104264U1 (de) | Vorrichtung zur Aufreinigung von Nukleinsäuren | |
EP2129464A1 (de) | Vorrichtung zur aufnahme, behandlung und aufbewahrung kleinvolumiger proben | |
EP1242816B1 (de) | Chromatographiematerial und verfahren unter verwendung desselben | |
DE10018788B4 (de) | Prozessieren von Proteinen aus Gelen für massenspektrometrische Analysen | |
EP1771242B1 (de) | Verfahren zur effizienten isolierung von nukleinsäuren | |
DE102007005655A1 (de) | Vorrichtung und Verfahren zur Aufreinigung von Nukleinsäuren | |
DE10238630A1 (de) | Verfahren zur Isolierung biologischer Makromoleküle sowie Vorrichtung zur Durchführung dieses Verfahrens | |
DE20114079U1 (de) | Vorrichtung zur Aufreinigung von Nukleinsäure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |